Provided by Tiger Trade Technology Pte. Ltd.

Mereo Biopharma Group Plc

0.2843
-0.0052-1.80%
Volume:823.62K
Turnover:235.23K
Market Cap:45.24M
PE:-1.62
High:0.2926
Open:0.2880
Low:0.2810
Close:0.2895
52wk High:2.37
52wk Low:0.2000
Shares:159.13M
Float Shares:131.00M
Volume Ratio:1.11
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1753
EPS(LYR):-0.2627
ROE:-67.85%
ROA:-42.46%
PB:1.58
PE(LYR):-1.08

Loading ...

Viridis puts huge US$1.86B value on Brazilian rare earths play

The West Australian
·
Aug 20

Mereo BioPharma Gets NASDAQ Extension to Regain $1 Minimum Bid Compliance

Reuters
·
Aug 19

Mereo Biopharma Group Plc : JP Morgan Cuts to Underweight from Neutral

THOMSON REUTERS
·
Aug 19

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live
·
Aug 17

Analysts Have Conflicting Sentiments on These Healthcare Companies: Achieve Life Sciences (ACHV), Mereo Biopharma Group Plc (MREO) and Demant (OtherWILLF)

TIPRANKS
·
Aug 17

UK's Akari Therapeutics Q2 Net Loss Widens on Higher R&D for AKTX-101

Reuters
·
Aug 14

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Switzerland's Pharvaris Q2 Loss Narrows, Cash Rises to €318 Mln

Reuters
·
Aug 12

Mereo BioPharma Group Price Target Maintained with a $1.00/Share by BTIG

Dow Jones
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and Inhibikase Therapeutics (IKT)

TIPRANKS
·
Aug 12

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Aug 11

Vor Biopharma Posts Wider-than-Expected Q2 Loss on Increased G&A Costs

Reuters
·
Aug 11

Sentynl Therapeutics and Mereo Biopharma Announce Option and License Agreement for Alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

Reuters
·
Aug 11

Mereo BioPharma Group PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Mereo BioPharma Q2 Operating Income USD -7.03 Million

Reuters
·
Aug 11

UK's Mereo BioPharma Q2 Loss Narrows on Lower R&D Spending

Reuters
·
Aug 11

Mereo BioPharma Group Q2 EPS $(0.01), Inline

Benzinga Earnings
·
Aug 11

Press Release: Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights

Dow Jones
·
Aug 11

Mereo BioPharma Signs Option-and-License Deal with Sentynl for US Rights to Alvelestat in AATD Lung Disease

Reuters
·
Aug 11